CN103242307B - 一种噁唑烷酮类衍生物晶型ⅰ及其制备方法和用途 - Google Patents
一种噁唑烷酮类衍生物晶型ⅰ及其制备方法和用途 Download PDFInfo
- Publication number
- CN103242307B CN103242307B CN201310183080.4A CN201310183080A CN103242307B CN 103242307 B CN103242307 B CN 103242307B CN 201310183080 A CN201310183080 A CN 201310183080A CN 103242307 B CN103242307 B CN 103242307B
- Authority
- CN
- China
- Prior art keywords
- oxo
- base
- oxazolidine
- thiophene
- pyridine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Description
Claims (6)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310183080.4A CN103242307B (zh) | 2013-05-17 | 2013-05-17 | 一种噁唑烷酮类衍生物晶型ⅰ及其制备方法和用途 |
PCT/CN2014/077666 WO2014183665A1 (zh) | 2013-05-17 | 2014-05-16 | 一种噁唑烷酮类衍生物晶型ⅰ及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310183080.4A CN103242307B (zh) | 2013-05-17 | 2013-05-17 | 一种噁唑烷酮类衍生物晶型ⅰ及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103242307A CN103242307A (zh) | 2013-08-14 |
CN103242307B true CN103242307B (zh) | 2015-08-12 |
Family
ID=48922212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310183080.4A Active CN103242307B (zh) | 2013-05-17 | 2013-05-17 | 一种噁唑烷酮类衍生物晶型ⅰ及其制备方法和用途 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN103242307B (zh) |
WO (1) | WO2014183665A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103232446B (zh) * | 2013-05-17 | 2015-09-23 | 天津药物研究院 | 一种噁唑烷酮衍生物晶型ⅱ及其制备方法和用途 |
CN106478661A (zh) * | 2015-08-25 | 2017-03-08 | 华北制药集团新药研究开发有限责任公司 | 苯并恶唑并恶嗪酮类化合物wa1-089的晶型e及其制备方法 |
CN106562981A (zh) * | 2015-10-13 | 2017-04-19 | 孙双勇 | 一种由知非沙班与人参皂苷Rb3组成的药物组合物及应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19962924A1 (de) * | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
DE102007028320A1 (de) * | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Substituierte Oxazolidinone und ihre Verwendung |
DE102007028406A1 (de) * | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Substituierte Oxazolidinone und ihre Verwendung |
DE102007028319A1 (de) * | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Substituierte Oxazolidinone und ihre Verwendung |
CN102464658B (zh) * | 2010-11-03 | 2014-04-16 | 天津药物研究院 | 噁唑烷酮衍生物及其制备方法和用途 |
CN103232446B (zh) * | 2013-05-17 | 2015-09-23 | 天津药物研究院 | 一种噁唑烷酮衍生物晶型ⅱ及其制备方法和用途 |
-
2013
- 2013-05-17 CN CN201310183080.4A patent/CN103242307B/zh active Active
-
2014
- 2014-05-16 WO PCT/CN2014/077666 patent/WO2014183665A1/zh active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CN103242307A (zh) | 2013-08-14 |
WO2014183665A1 (zh) | 2014-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102464658B (zh) | 噁唑烷酮衍生物及其制备方法和用途 | |
CN103242307B (zh) | 一种噁唑烷酮类衍生物晶型ⅰ及其制备方法和用途 | |
Tsakiridis et al. | Effect of lornoxicam in lung inflammatory response syndrome after operations for cardiac surgery with cardiopulmonary bypass | |
EA020531B1 (ru) | КОМБИНИРОВАННАЯ ТЕРАПИЯ АНТИКОАГУЛИРУЮЩЕГО СРЕДСТВА С СОЕДИНЕНИЕМ, КОТОРОЕ ДЕЙСТВУЕТ КАК ИНГИБИТОР ФАКТОРА Ха | |
CN103232446B (zh) | 一种噁唑烷酮衍生物晶型ⅱ及其制备方法和用途 | |
JPS63126866A (ja) | ピペリジン化合物、その製造方法及びその使用方法 | |
CN104072434B (zh) | 间位取代的四氮唑苯乙酮化合物、其制备方法和用途 | |
CN104098520B (zh) | 苯基三唑希夫碱类化合物、其制备方法和用途 | |
CN115381827B (zh) | 苯骈三氮唑烷基衍生物在制备治疗或预防心血管疾病的药物中的应用 | |
CN104936590A (zh) | 用于低血压复苏的方法和组合物 | |
CN104163819A (zh) | 一种噁唑烷酮衍生物的乙酸溶剂化物及其制备方法和用途 | |
Romsi et al. | Fructose-1, 6-bisphosphate for improved outcome after hypothermic circulatory arrest in pigs | |
CN102406938A (zh) | 一种抗血栓的药物组合物 | |
Berkova et al. | Arrhythmias and ECG changes in life threatening hyperkalemia in older patients treated by potassium sparing drugs | |
CN105748424A (zh) | 一种稳定的硫酸氢氯吡格雷阿司匹林双层片及其制备方法 | |
CN101023942A (zh) | 二氢杨梅素治疗心血管疾病的用途 | |
RU2014151360A (ru) | Производные пиразола и их применение в качестве lpar5 антагонистов | |
CN102796040B (zh) | 1,4-二取代哌嗪衍生物、其制备方法和用途 | |
CN104086497B (zh) | 三唑希夫碱类化合物、其制备方法和用途 | |
RU2798587C1 (ru) | ЛЕКАРСТВЕННОЕ СРЕДСТВО, ОБЛАДАЮЩЕЕ АНТИКОАГУЛЯНТНОЙ (ИНГИБИТОР IIA ФАКТОРА), АНТИТРОМБОТИЧЕСКОЙ, ПРОТИВОВОСПАЛИТЕЛЬНОЙ АКТИВНОСТЯМИ И СОДЕРЖАЩЕЕ 5,7-ДИ(ТИОФЕН-2-ИЛ)-4,5-ДИГИДРО-[1,2,4]ТРИАЗОЛО[1,5-а]ПИРИМИДИН | |
CN104086495B (zh) | 末端双取代的三唑希夫碱结构化合物、其制备方法和用途 | |
CN104086496B (zh) | 一种抗血栓化合物、其制备方法和用途 | |
CN107400089A (zh) | 基于txa2/ros双靶点的抗脑卒中的阿司匹林孪药的制备方法及其应用 | |
CN105111119B (zh) | 一类卤代苯l‑薄荷醇类p2y12受体拮抗剂及其用途 | |
Heikkinen et al. | Apotransferrin, C1‐esterase inhibitor, and alpha 1‐acid glycoprotein for cerebral protection during experimental hypothermic circulatory arrest |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Applicant after: TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. Address before: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Applicant before: Tianjin Institute of Pharmaceutical Research |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH TO: TIANJIN PHARMACEUTICAL INSTITUTE CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201012 Address after: 300171 No. eight, No. 109, Hedong Road, Hedong District, Tianjin Patentee after: Tianjin Drug Group Ltd. Address before: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Patentee before: Tianjin Institute of Pharmaceutical Research Co.,Ltd. |
|
TR01 | Transfer of patent right |